InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: shadolane post# 243302

Saturday, 01/25/2020 4:11:45 PM

Saturday, January 25, 2020 4:11:45 PM

Post# of 428756
s-

I expected an offer in Q1 2019 but I revised it (IRCC) in Q2 19 (or sometimes in 2019) as after FDA approval and Order.

Meanwhile a BO is not guaranteed I could not imagine that nobody interested in Vascepa (at least offer will be (was? but low) submitted).

I see Q2 2020 as a reasonable time for it … after the Order. (plus: Amarin will know the list of questions regarding EU submission … or - not likely - the Opinion / recommendation for approval by end of March.)

(i) Amarin win the litigation
(ii) (short) list of questions regarding EU submission … or Opinion



Best,
G

"There are some things money can't buy. … For these, there is AMRN."

Disclosure: I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News